Valuation: Coral Laboratories Limited

Market Cap 1.73B 18.22M 16.32M 15.01M 13.6M 25.43M 25.9M 179M 71.87M 910M 68.39M 66.94M 2.87B P/E 2025
10.4x
P/E 2026 8.08x
Enterprise Value 1.47B 15.45M 13.83M 12.73M 11.53M 21.55M 21.96M 152M 60.92M 772M 57.97M 56.74M 2.43B EV / Sales 2025
1.94x
EV / Sales 2026 1.23x
Free-Float
19.97%
Yield 2025
0.21%
Yield 2026 0.54%
1 day-6.86%
1 week-4.46%
Current month-14.73%
1 month-11.13%
3 months-12.77%
6 months+15.02%
Current year+10.46%
1 week 480.2
Extreme 480.2
540
1 month 475.7
Extreme 475.7
638.7
Current year 360
Extreme 360
679
1 year 360
Extreme 360
679
3 years 275.1
Extreme 275.1
999
5 years 217
Extreme 217
999
10 years 81.2
Extreme 81.2
1,190
Manager TitleAgeSince
Director of Finance/CFO 49 2017-05-25
Director TitleAgeSince
Director/Board Member 45 2017-05-25
Director/Board Member 49 2017-05-25
Director/Board Member 40 2019-05-27
Change 5-day change 1-year change 3-year change Capi.($)
-6.86%-4.46%-2.94%+67.83% 19.51M
+3.19%+8.48%+74.25%+153.03% 1,224B
-0.73%+2.09%+46.41%+87.64% 662B
+1.41%+3.40%+30.98%+112.26% 514B
+0.42%+2.88%+54.92%+69.67% 388B
+2.18%+1.55%+72.70%+45.42% 361B
+1.12%+3.80%+35.82%+59.72% 302B
+6.96%+7.55%+11.15%+37.89% 271B
+1.15%+4.19%+59.72%+78.16% 249B
+3.06%+8.58%+44.03%+122.76% 205B
Average +1.25%+2.59%+42.70%+83.44% 417.69B
Weighted average by Cap. +1.95%+3.04%+53.35%+100.42%

Financials

2025 2026
Net sales 1.15B 12.11M 10.85M 9.98M 9.04M 16.9M 17.22M 119M 47.77M 605M 45.46M 44.49M 1.91B 859M 9.05M 8.1M 7.45M 6.75M 12.62M 12.86M 88.88M 35.68M 452M 33.95M 33.23M 1.42B
Net income 242M 2.54M 2.28M 2.1M 1.9M 3.55M 3.62M 24.99M 10.03M 127M 9.55M 9.34M 401M 164M 1.73M 1.55M 1.42M 1.29M 2.41M 2.45M 16.95M 6.8M 86.17M 6.47M 6.34M 272M
Net Debt -274M -2.88M -2.58M -2.38M -2.15M -4.02M -4.1M -28.34M -11.38M -144M -10.83M -10.6M -454M -264M -2.78M -2.49M -2.29M -2.07M -3.88M -3.95M -27.29M -10.95M -139M -10.42M -10.2M -437M
Projected Income Statement - Annual - Coral Laboratories Limited
Logo Coral Laboratories Limited
Coral Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in the business of pharmaceutical formulations. The Company is engaged in the manufacturing of generic - branded, nutraceuticals, over the counter (OTC), and herbal medicines. It offers dosage forms, which include tablets, capsules, liquid orals, injections (liquids and powder), ointment and creams, gels and lotions, and suppositories. Its product categories include nutraceutical, OTC, sterile and non-sterile. Its nutraceutical products include DAX 200, DAX 400 Drops, Zest drops, and Super Zestcal Tablets. Its OTC products include herbal range, skin care, medical devices, and effervescent range. Its sterile products include small volume liquid - injectables, lyophilized range - injectables, eye drops, and eardrops. Its non-sterile antibiotics/antibacterials, antifungals, gastro-intestinal drugs, anti-emetics, and muscle relaxants. The Company also exports its products to various countries.
Employees
149
Date Price Change Volume
26-10-30 ₹484.35 -6.86% 2,026
26-10-29 ₹520.00 +3.71% 743
26-10-28 ₹501.40 +2.09% 112
26-10-27 ₹491.15 -1.75% 406
26-10-26 ₹499.90 +1.17% 522
  1. Stock Market
  2. Stocks
  3. CORALAB6 Stock